Human and financial cost of healthcare-associated pneumonia with Dr Dian Baker at the 2022 SHEA Spring Meeting

In this episode recorded at the 2022 SHEA Sprong meeting, Martin Kiernan talks to Dr Dian Baker, Emeritus Professor at California State University, Sacramento, USA. Dian has been a passionate advocate for action against healthcare-onset non-ventilator associated pneumonia (nVHAP) for over 12 years and as ever, it was a personal experience that motivated her to look into this important topic. Apart from the human cost, nVHAP is responsible for use of antibiotics and means huge costs for healthcare systems globally. Some of Dian's key papers are listed here:

1. Baker DL, et al. Prevention practices for nonventilator hospital-acquired pneumonia: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). Infect Control Hosp Epidemiol. 2021:1-2.  http:

2. Quinn B, et al. Non-ventilator health care-associated pneumonia (NV-HAP): Best practices for prevention of NV-HAP. Am J Infect Control. 2020;48(5S):A23-A27.  https://doi.org/10.1016/j.ajic.2020.03.006

3. Giuliano KK, et al. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(3):322-327.  https://doi.org/10.1016/j.ajic.2017.09.005

4. Baker D, et al. Hospital Acquired Pneumonia Prevention Initiative-2: Incidence of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(1):2-7.  https://doi.org/10.1016/j.ajic.2017.08.036

5. Quinn B, et al. Basic nursing care to prevent nonventilator hospital-acquired pneumonia. J Nurs Scholarsh. 2014;46(1):11-19.  https://doi.org/10.1111/jnu.12050